We are dedicated to researching and developing novel therapeutics for the treatment of cancer, autoimmune, cardiovascular diseases, and other serious unmet medical needs
We have established a comprehensive quality management system in compliance with requirements applicable to and enforced by global competent authorities
Explore further
龙8生物制 药 股份有限公司 ( 上交所代 码 ： 688177) 是一家位于中国广州，基于科学而 创 新的全球性生物制 药 企 业 ，以下 简 称 “ 龙8 ” 或 “...
Guangzhou, China– June 2 , 2024 – Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical companydeveloping a pipeline of innovative therapies and biosimilars, will present apost...
Bio-Theraand STADA h ave reached an exclusive commercialization and license agreement forBAT2506, a biosimilar candidate to Simponi ® (golimumab) Bio-Thera will maintain responsibility fordevelopment,...
